Effect of Brivaracetam in Photosensitive Epileptic Subjects

• Status: Completed
• Trial end date: 2003-06-01
• Target enrollment: 0
• Participant gender: All

Summary

to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma
• Treatments: Brivaracetam

Criteria

Inclusion Criteria:

• epileptic subjects with generalized PPR

Exclusion Criteria:

• more than 2 concomitant antiepileptic drugs